Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
, , , , e
29 gen 2024
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 29 gen 2024
Pagine: 93 - 100
Ricevuto: 01 nov 2023
Accettato: 04 dic 2023
DOI: https://doi.org/10.2478/rrlm-2024-0003
Parole chiave
© 2024 Melen Brinza et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Brinza, Melen
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari BvdBucharest, Romania
Uscatescu, Valentina
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari BvdBucharest, Romania
Hemcinschi, Mihai
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Chiriac, Elisabeta
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Gherghe, Georgiana
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Coriu, Daniel
Centre of Hematology and Bone Marrow Transplant, Fundeni Clinical InstituteBucharest, Romania
Carol Davila University of Medicine and Pharmacy, Eroii Sanitari BvdBucharest, Romania